ASX - By Stock
|
RCE |
Re:
Ann: Placement and Entitlement Offer
|
|
Bpharma
|
101 |
35K |
4 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
101
|
35K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Placement and Entitlement Offer
|
|
Bpharma
|
101 |
35K |
2 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
101
|
35K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Placement and Entitlement Offer
|
|
Bpharma
|
101 |
35K |
3 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
101
|
35K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Placement and Entitlement Offer
|
|
Bpharma
|
101 |
35K |
5 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
101
|
35K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Placement and Entitlement Offer
|
|
Bpharma
|
101 |
35K |
1 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
101
|
35K
|
1
|
|
ASX - By Stock
|
JGH |
Re:
Ann: Jade Gas Advances Toward Gas Pilot Production
|
|
Bpharma
|
14 |
5.1K |
0 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
14
|
5.1K
|
0
|
|
ASX - By Stock
|
JGH |
Re:
Ann: Jade Gas Advances Toward Gas Pilot Production
|
|
Bpharma
|
14 |
5.1K |
1 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
14
|
5.1K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Need to push the IV dose higher
|
|
Bpharma
|
26 |
10K |
1 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
26
|
10K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Need to push the IV dose higher
|
|
Bpharma
|
26 |
10K |
1 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
26
|
10K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Need to push the IV dose higher
|
|
Bpharma
|
26 |
10K |
3 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
26
|
10K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Placement and Entitlement Offer
|
|
Bpharma
|
101 |
35K |
3 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
101
|
35K
|
3
|
|
ASX - By Stock
|
PVE |
Re:
Ann: Po Valley Energy Investor Presentation
|
|
Bpharma
|
31 |
13K |
1 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
31
|
13K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
News: RCE Recce Pharmaceuticals Says A$8 Million Commitments Received In Placement
|
|
Bpharma
|
14 |
5.6K |
9 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
14
|
5.6K
|
9
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Trading Halt
|
|
Bpharma
|
66 |
18K |
1 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
66
|
18K
|
1
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Voyager Project Update
|
|
Bpharma
|
42 |
9.5K |
7 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
42
|
9.5K
|
7
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Voyager Project Update
|
|
Bpharma
|
42 |
9.5K |
3 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
42
|
9.5K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Opening R&D Address at World AMR Congress
|
|
Bpharma
|
6 |
2.6K |
12 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
6
|
2.6K
|
12
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Appendix 4E and Unaudited Preliminary Report
|
|
Bpharma
|
20 |
6.6K |
3 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
20
|
6.6K
|
3
|
|
ASX - By Stock
|
BNL |
Re:
News: BNL Blue Star Helium Says Key Feed Compressor Infrastructure Secured For Voyager Helium
|
|
Bpharma
|
3 |
1.3K |
0 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
3
|
1.3K
|
0
|
|
ASX - By Stock
|
PVE |
Re:
Ann: Po Valley Energy Investor Presentation
|
|
Bpharma
|
31 |
13K |
2 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
31
|
13K
|
2
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Voyager Helium Development Update
|
|
Bpharma
|
138 |
34K |
1 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
138
|
34K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Appendix 4E and Unaudited Preliminary Report
|
|
Bpharma
|
20 |
6.6K |
2 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
20
|
6.6K
|
2
|
|
ASX - By Stock
|
5EA |
Re:
5EA set to skyrocket
|
|
Bpharma
|
1.6K |
839K |
3 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
1.6K
|
839K
|
3
|
|
ASX - By Stock
|
PVE |
Re:
Ann: Successful ramp-up and commissioning at PVE's PM-1
|
|
Bpharma
|
13 |
6.1K |
2 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
13
|
6.1K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Additional Positive Patient Cases - Special Access Scheme
|
|
Bpharma
|
24 |
7.7K |
1 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
24
|
7.7K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Additional Positive Patient Cases - Special Access Scheme
|
|
Bpharma
|
24 |
7.7K |
19 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
24
|
7.7K
|
19
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Additional Positive Patient Cases - Special Access Scheme
|
|
Bpharma
|
24 |
7.7K |
9 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
24
|
7.7K
|
9
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Additional Positive Patient Cases - Special Access Scheme
|
|
Bpharma
|
24 |
7.7K |
11 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
24
|
7.7K
|
11
|
|
ASX - By Stock
|
5EA |
Re:
5EA set to skyrocket
|
|
Bpharma
|
1.6K |
839K |
0 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
1.6K
|
839K
|
0
|
|
ASX - By Stock
|
5EA |
Re:
Ann: 5EA - Form 10-K - Annual Results
|
|
Bpharma
|
25 |
11K |
0 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
25
|
11K
|
0
|
|
ASX - By Stock
|
5EA |
Re:
5EA set to skyrocket
|
|
Bpharma
|
1.6K |
839K |
0 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
1.6K
|
839K
|
0
|
|
ASX - By Stock
|
EUR |
Re:
News: EUR European Lithium Announces Updates on NASDAQ Listing
|
|
Bpharma
|
50 |
16K |
0 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
50
|
16K
|
0
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Voyager Helium Development Update
|
|
Bpharma
|
138 |
34K |
1 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
138
|
34K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Bpharma
|
4.2K |
3.8M |
6 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
4.2K
|
3.8M
|
6
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Bpharma
|
974 |
325K |
1 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
974
|
325K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Patients Dosed in R327 Diabetic Foot Infection Trial
|
|
Bpharma
|
10 |
3.9K |
5 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
10
|
3.9K
|
5
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Voyager Helium Development Update
|
|
Bpharma
|
138 |
34K |
3 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
138
|
34K
|
3
|
|
ASX - By Stock
|
BNL |
Re:
Ann: Voyager Helium Development Update
|
|
Bpharma
|
138 |
34K |
6 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
138
|
34K
|
6
|
|
ASX - By Stock
|
JGH |
Re:
This Company has potential
|
|
Bpharma
|
1 |
1.0K |
2 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
1
|
1.0K
|
2
|
|
ASX - By Stock
|
EUR |
Re:
EUROPEAN LITHIUM LIMITED
|
|
Bpharma
|
4.9K |
1.5M |
4 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
4.9K
|
1.5M
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Patients Update - Special Access Scheme
|
|
Bpharma
|
124 |
41K |
11 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
124
|
41K
|
11
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Patients Update - Special Access Scheme
|
|
Bpharma
|
124 |
41K |
2 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
124
|
41K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Patients Update - Special Access Scheme
|
|
Bpharma
|
124 |
41K |
0 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
124
|
41K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Patients Update - Special Access Scheme
|
|
Bpharma
|
124 |
41K |
5 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
124
|
41K
|
5
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Patients Update - Special Access Scheme
|
|
Bpharma
|
124 |
41K |
9 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
124
|
41K
|
9
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Patients Update - Special Access Scheme
|
|
Bpharma
|
124 |
41K |
3 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
124
|
41K
|
3
|
|
ASX - By Stock
|
PVE |
Re:
Ann: Successful ramp-up and commissioning at PVE's PM-1
|
|
Bpharma
|
13 |
6.1K |
1 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
13
|
6.1K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Patients Update - Special Access Scheme
|
|
Bpharma
|
124 |
41K |
12 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
124
|
41K
|
12
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Patients Update - Special Access Scheme
|
|
Bpharma
|
124 |
41K |
6 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
124
|
41K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Patients Update - Special Access Scheme
|
|
Bpharma
|
124 |
41K |
8 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
124
|
41K
|
8
|
|